Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients

► We study long-term immunogenicity of influenza vaccine in hemodialysis patients. ► Immunogenicity was similar in hemodialysis patients and controls. ► Immunogenicity declined by 24 weeks after vaccination in hemodialysis patients.